Journal Section:
Hemodialysis
References
1.
Jager
KJ
, Kovesdy
C
, Langham
R
, Rosenberg
M
, Jha
V
, Zoccali
C
. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases
. Kidney Int
. 2019
;96
(5
):1048
–50
. 2.
Bello
AK
, Okpechi
IG
, Osman
MA
, Cho
Y
, Htay
H
, Jha
V
, et al. Epidemiology of haemodialysis outcomes
. Nat Rev Nephrol
. 2022
;18
(6
):378
–95
. 3.
IQTIG [Institut für Qualitätssicherung und Transparenz im Gesundheitswesen]
. Jahresbericht 2018 zur Qualität in der Dialyse. Anlage 2 zum Beschluss
. 2019a
. G-BA [Gemeinsamer Bundesausschuss]: Beschluss des Gemeinsamen Bundesausschusses über die Veröffentlichung des Jahresberichts 2018 zur Qualität in der Dialyse. [Stand: 10.07.2019]. Berlin: G-BA. URL: https://www.g-ba.de/downloads/39-261-3977/2019-09-19_QSD-RL_IQTIG-Jahresbericht-2018-Datenanalysten.pdf (accessed on October 29, 2024).4.
Vincent
JL
, Lefrant
JY
, Kotfis
K
, Nanchal
R
, Martin-Loeches
I
, Wittebole
X
, et al. Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP)
. Intensive Care Med
. 2018
;44
(3
):337
–44
. 5.
Blagg
CL
. From miracle to mainstream: creating the world’s first dialysis organization
. Northwest Kidney Centers
; 2017
.6.
Haas
G
. Über Versuche der Blutanswaschung am Lebenden mit Hilfe der Dialyse
. Archiv F Experiment Pathol U Pharmakol
. 1926
;116
(3–4
):158
–72
. 7.
Haas
G
. Über Versuche der Blutauswaschung am Lebenden mit Hilfe der Dialyse
. Archiv F Experiment Pathol U Pharmakol
. 1927
;120
(5–6
):371
–86
. 8.
Enke
E
. Einblicke ins Labor: Georg Haas, die Hämodialyse und der Film “Blutwäsche bei einem Hund”. In: Enke E: Die Medizinische Fakultät der Universität Gießen: Institutionen, Akteure und Ereignisse von der Gründung 1607 bis ins 20 Jahrhundert. Stuttgart; Steiner
; 2007
. p. 351
–68
.9.
Deutsche
Digitale
Bibliothek. Blutwäsche bei einem Hund
. https://www.deutsche-digitale-bibliothek.de/item/DOCDMTK547CNILFXVTUDO4RIU7CCS7N4?isThumbnailFiltered=true&query=Blutwäsche+an+einem+hund&rows=20&offset=0&viewType=list&hitNumber=1(accessed on November 30, 2024)
.10.
Enke
U.
90
Jahre „Blutwaschung am Lebenden
”. Spiegel der Forschung
. 2005
;22
:18
–25
. https://jlupub.ub.uni-giessen.de/server/api/core/bitstreams/c9ff2e4b-fc2f-48de-b804-eefd4e9eff4a/content(accessed on November 30, 2024)
.11.
Haas
G
. Versuche der Blutauswaschung am Lebenden mit Hilfe der Dialyse
. Klin Wochenschr
. 1925
;4
(1
):13
–4
. 12.
Benedum
J
. The early history of the artificial kidney
. Anasthesiol Intensivmed Notfallmed Schmerzther
. 2003
;38
(11
):681
–8
. 13.
14.
Leber
HW
, Wizemann
V
, Goubeaud
G
, Rawer
P
, Schutterle
G
. Hemodiafiltration: a new alternative to hemofiltration and conventional hemodialysis
. Artif Organs
. 1978
;2
(2
):150
–3
. 15.
Ledebo
I
. Development of hemodiafiltration therapy: a historical perspective
. Blood Purif
. 2013
;35
(Suppl 1
):6
–10
. 16.
Birk
HW
. Peritonealdialyse. Hessisches Ärzteblatt
, 7/8
. Landesärztekammer Hessen
; 2023
. p. 432
–7
.17.
Biesen
WV
, Vanholder
RC
, Veys
N
, Dhondt
A
, Lameire
NH
. An evaluation of an integrative care approach for end-stage renal disease patients
. J Am Soc Nephrol
. 2000
;11
(1
):116
–25
. 18.
Bundesverband Niere e.V
. http://www.bundesverband-niere.de/ueber-uns/gremienarbeit (accessed on December 2, 2024).19.
Medical Netcare GmbH
. Jahresberichte zur Qualitätssicherung in der Dialyse
. https://m-nc.de/qs-dialyse-jahresberichte (accessed on December 2, 2024).20.
McCullough
KP
, Morgenstern
H
, Rayner
HC
, Port
FK
, Jadoul
MY
, Akizawa
T
, et al. Explaining international trends in mortality on hemodialysis through changes in hemodialysis practices in the dialysis outcomes and practice patterns study (DOPPS)
. Am J Kidney Dis
. 2025
;85
(1
):25
–35.e1
. 21.
Chesnaye
NC
, Ortiz
A
, Zoccali
C
, Stel
VS
, Jager
KJ
. The impact of population ageing on the burden of chronic kidney disease
. Nat Rev Nephrol
. 2024
;20
(9
):569
–85
. 22.
ISN Global Kidney Health Atlas
2023
. https://www.theisn.org/wp-content/uploads/media/ISN%20Atlas_2023%20Digital_REV_2023_10_03.pdf (accessed on December 1, 2024).23.
Foreman
KJ
, Marquez
N
, Dolgert
A
, Fukutaki
K
, Fullman
N
, McGaughey
M
, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories
. Lancet
. 2018
;392
(10159
):2052
–90
. 24.
Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM) und Deutsche Gesellschaft für Nephrologie (DGfN). S3-Leitlinie zur Versorgung von Patient*innen mit chronischer, nicht-nierenersatztherapiepflichtiger Nierenkrankheit in der Hausarztpraxis
. Juni
. 2024
. https://register.awmf.org/de/leitlinien/detail/053-048 (accessed on December 1, 2024).25.
Visseren
FLJ
, Mach
F
, Smulders
YM
, Carballo
D
, Koskinas
KC
, Back
M
, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
. Eur Heart J
. 2021
;42
(34
):3227
–337
. 26.
Merker
L
, Ebert
T
, Guthoff
M
, Isermann
B
. Nephropathy in diabetes
. Exp Clin Endocrinol Diabetes
. 2023
;131
(1–02
):61
–5
. 27.
Wanner
C
, Busch
M
. New guideline on diabetes management in chronic kidney disease
. Inn Med (Heidelb)
. 2023
;64
(3
):219
–24
. 28.
Hahn
KM
, Strutz
F
. The early diagnosis and treatment of chronic renal insufficiency
. Dtsch Arztebl Int
. 2024
;121
(13
):428
–35
. 29.
Husain-Syed
F
, Grone
HJ
, Assmus
B
, Bauer
P
, Gall
H
, Seeger
W
, et al. Congestive nephropathy: a neglected entity? Proposal for diagnostic criteria and future perspectives
. ESC Heart Fail
. 2021
;8
(1
):183
–203
. © 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended...
© 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.